Blue Wolf sells PSG to Omnicell for $225m

Blue Wolf Capital Partners has sold Pharmaceutical Strategies Group to Omnicell Inc.

2 October 2020•3 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Walter Capital Partners takes significant stake in Quebec educational games maker Passe-Temps

3 hours ago · 1 min read

Truelink Capital’s GES buys CSG Creative from National Trade Productions

3 hours ago · 2 mins read

MPE Partners’ Intermatic adds outdoor lighting-control products maker Sun-Tech

3 hours ago · 2 mins read

Velocity Capital Management backs founder Griffin Haddrill with stake in LV8, Mirage

4 hours ago · 1 min read

Aterian’s Outlook Group completes acquisition of Graham-backed ABX’s Pewaukee packaging facility

4 hours ago · 1 min read

FPE Capital’s NoBlue2 adds PeopleWalking’s Spanish NetSuite business in Europe push

4 hours ago · 1 min read

PE targets identity security as AI transforms threats: 6 deals

6 hours ago · 3 mins read